Biosergen AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '19 Dec 31, 2019
Cash & Equivalents	22.71	50.61	1.88	29.34	21.67	-
Cash & Short-Term Investments	22.71	50.61	1.88	29.34	21.67	-
Cash Growth	121.76%	2587.84%	-93.58%	35.44%	-	-
Other Receivables	2.81	1.95	4.93	4.02	7.47	-
Receivables	2.81	1.95	4.93	4.02	7.47	-
Prepaid Expenses	-	0.46	0.39	0.43	0.35	-
Other Current Assets	-	-	-	-	-	1.47
Total Current Assets	25.52	53.02	7.2	33.79	29.49	1.47
Property, Plant & Equipment	-	-	-	-	-	5.2
Other Long-Term Assets	-	-	-	-	-	-0
Total Assets	25.52	53.02	7.2	33.79	29.49	6.66
Accounts Payable	-	2.38	1.7	6.81	6.75	-
Accrued Expenses	-	2.4	3.26	4	2.41	-
Other Current Liabilities	5.26	0.03	0.13	0.18	0.1	-
Total Current Liabilities	5.26	4.81	5.09	11	9.25	-
Other Long-Term Liabilities	-	-	-	-	-0	11.34
Total Liabilities	5.26	4.81	5.09	11	9.25	11.34
Common Stock	20.26	5.87	1.27	1.06	0.7	-4.68
Comprehensive Income & Other	-	42.34	0.85	21.73	19.53	-
Shareholders' Equity	20.26	48.21	2.12	22.79	20.23	-4.68
Total Liabilities & Equity	25.52	53.02	7.2	33.79	29.49	6.66
Net Cash (Debt)	22.71	50.61	1.88	29.34	21.67	-
Net Cash Growth	121.76%	2587.84%	-93.58%	35.44%	-	-
Net Cash Per Share	6.55	21.09	3.69	93.93	77.02	-
Filing Date Shares Outstanding	2.35	2.35	0.51	0.42	0.28	0.23
Total Common Shares Outstanding	2.35	2.35	0.51	0.42	0.28	0.23
Working Capital	20.26	48.21	2.12	22.79	20.23	1.47
Book Value Per Share	8.63	20.53	4.17	53.72	72.00	-20.26
Tangible Book Value	20.26	48.21	2.12	22.79	20.23	-4.68
Tangible Book Value Per Share	8.63	20.53	4.17	53.72	72.00	-20.26

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.